Cryptic EWSR1-FLI1 fusions in Ewing sarcoma: potential pitfalls in the diagnostic use of fluorescence in situ hybridization probes

被引:12
|
作者
Newby, Rachel [1 ]
Rowe, David [1 ]
Paterson, Lindsay [2 ]
Farquharson, Maura A. [3 ]
MacDuff, Elaine [4 ]
Coupe, Amanda [1 ]
Hale, Juliet [5 ]
Dildey, Petra [6 ]
Bown, Nick [1 ]
机构
[1] Inst Human Genet, No Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[2] Yorkhill Hosp, Inst Med Genet, Glasgow GS 8SJ, Lanark, Scotland
[3] Royal Infirm, Dept Pathol, Glasgow G4 0SF, Lanark, Scotland
[4] Western Infirm & Associated Hosp, Dept Pathol, Glasgow G11 6NT, Lanark, Scotland
[5] Royal Victoria Infirm, Dept Paediat Oncol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[6] Royal Victoria Infirm, Dept Cellular Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
GENE; INSERTION; TUMORS;
D O I
10.1016/j.cancergencyto.2010.03.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Detection of EWSR1 translocations - particularly t(11;22)(q24;q12) - is of great value in the differential diagnosis of the Ewing family of tumors. We report two cases that highlight the problems and pitfalls of identifying Ewing tumors using conventional chromosome analysis and a commercial EWSR1 fluorescence in situ hybridization (FISH) probe. In both cases, the tumor karyotype was abnormal, but a visible t(11;22)(q24;q12) was not present. The commercial EWSR1 "break-apart" probe was not split in either case. Reverse-transcriptase polymerase chain reaction (RT-PCR) analysis, however, identified EWSR1-FLI1 fusion transcripts in both tumors, and the gene fusions were corroborated by FISH analysis with "in house" probes and confirmed by sequencing RT-PCR products. The occurrence of cryptic EWSR1-FLI1 fusions mandates that RT-PCR should be performed, particularly in those cases in which the genetic findings are not in agreement with the histologic picture. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:60 / 64
页数:5
相关论文
共 50 条
  • [41] Are EWSR1-FLI-positive cell lines from patients with other diagnoses than Ewing sarcoma really Ewing sarcoma cell lines?
    Staege, Martin S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
  • [42] Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex
    Mo, Jialin
    Tan, Kezhe
    Dong, Yu
    Lu, Wenjie
    Liu, Fang
    Mei, Yanqing
    Huang, Hongting
    Zhao, Kewen
    Lv, Zhibao
    Ye, Youqiong
    Tang, Yujie
    ONCOGENE, 2023, 42 (01) : 11 - 25
  • [43] Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex
    Jialin Mo
    Kezhe Tan
    Yu Dong
    Wenjie Lu
    Fang Liu
    Yanqing Mei
    Hongting Huang
    Kewen Zhao
    Zhibao Lv
    Youqiong Ye
    Yujie Tang
    Oncogene, 2023, 42 : 11 - 25
  • [44] The Evaluation of CD99 Immunoreactivity and EWS/FLI1 Translocation by Fluorescence in situ Hybridization in Central PNETs and Ewing's Sarcoma Family of Tumors
    Vural, Cigdem
    Uluoglu, Omer
    Akyurek, Nalan
    Oguz, Aynur
    Karadeniz, Ceyda
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 619 - 625
  • [45] Extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation associated with EWSR1(Ewing sarcoma breakpoint region 1)/FLI1 translocation without prior chemotherapy
    Vali, K.
    Kokta, V.
    Beaunoyer, M.
    Fetni, R.
    Teira, P.
    Sartelet, Herve
    HUMAN PATHOLOGY, 2012, 43 (10) : 1772 - 1776
  • [46] Ewing Sarcoma Fusion Protein EWSR1/FLI1 Interacts with EWSR1 Leading to Mitotic Defects in Zebrafish Embryos and Human Cell Lines
    Embree, Lisa J.
    Azuma, Mizuki
    Hickstein, Dennis D.
    CANCER RESEARCH, 2009, 69 (10) : 4363 - 4371
  • [47] Malignant gastrointestinal neuroectodermal tumor as a second malignancy following Ewing sarcoma: Diagnostic pitfalls in the EWSR1-rearranged tumor spectrum
    Khneisser, Pierre
    Bani, Mohamed-Amine
    Cotteret, Sophie
    Labaied, Nizar
    Honore, Charles
    Guimard, Gregory
    Berlanga, Pablo
    Scoazec, Jean-Yves
    PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [48] Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma
    Yamamoto, Yoshinari
    Yamazaki, Kazuto
    Ishida, Yasuo
    JOURNAL OF CYTOLOGY, 2015, 32 (01) : 30 - 32
  • [49] The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma
    Banday, Shahid
    Mishra, Alok K.
    Rashid, Romana
    Ye, Tianyi
    Ali, Amjad
    Li, Junhui
    Yustein, Jason T.
    Kelliher, Michelle A.
    Zhu, Lihua Julie
    Deibler, Sara K.
    Malonia, Sunil K.
    Green, Michael R.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [50] Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization
    Krystel-Whittemore, Melissa
    Taylor, Martin S.
    Rivera, Miguel
    Lennerz, Jochen K.
    Le, Long P.
    Dias-Santagata, Dora
    Iafrate, Anthony John
    Deshpande, Vikram
    Chebib, Ivan
    Nielsen, Gunnlaugur Petur
    Wu, Chin-Lee
    Nardi, Valentina
    HUMAN PATHOLOGY, 2019, 93 : 65 - 73